CoChat

C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes

Open access
Tavano, Regina, Gabrielli, Luca, Lubian, Elisa, Fedeli, Chiara, Visentin, Silvia, Polverino De Laureto, Patrizia, Arrigoni, Giorgio, Geffner-Smith, Alessandra, Chen, Fangfang, Simberg, Dmitri, Morgese, Giulia, Benetti, Edmondo M., Wu, Linping, Moghimi, Seyed Moein, Mancin, Fabrizio, Papini, Emanuele · 2018 · ACS Nano
Cited by 141

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Poly(2-methyl-2-oxazoline) (PMOXA) is an alternative promising polymer to poly(ethylene glycol) (PEG) for design and engineering of macrophage-evading nanoparticles (NPs). Although PMOXA-engineered NPs have shown comparable pharmacokinetics and in vivo performance to PEGylated stealth NPs in the murine model, its interaction with elements of the human innate immune system has not been studied. From a translational angle, we studied the interaction of fully characterized PMOXA-coated vinyltriethoxysilane-derived organically modified silica NPs (PMOXA-coated NPs) of approximately 100 nm in diameter with human complement system, blood leukocytes, and macrophages and compared their performance with PEGylated and uncoated NP counterparts. Through detailed immunological and proteomic profiling, we show that PMOXA-coated NPs extensively trigger complement activation in human sera exclusively through the classical pathway. Complement activation is initiated by the sensing molecule C1q, where C1q binds with high affinity ( K d = 11 ± 1 nM) to NP surfaces independent of immunoglobulin binding. C1q-mediated complement activation accelerates PMOXA opsonization with the third complement protein (C3) through the amplification loop of the alternative pathway. This promoted NP recognition by human blood leukocytes and monocyte-derived macrophages. The macrophage capture of PMOXA-coated NPs correlates with sera donor variability in complement activation and opsonization but not with other major corona proteins, including clusterin and a wide range of apolipoproteins. In contrast to these observations, PMOXA-coated NPs poorly activated the murine complement system and were marginally recognized by mouse macrophages. These studies provide important insights into compatibility of engineered NPs with elements of the human innate immune system for translational steps.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.8b01806

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 58

  1. 10.1146/annurev-pharmtox-010611-134623 · DOI · Paper page
  2. 10.1159/000339153 · DOI
  3. 10.1038/nnano.2012.237 · DOI · Paper page
  4. 10.2217/nnm.15.163 · DOI · Paper page
  5. 10.2165/00003088-200342050-00002 · DOI · Paper page
  6. 10.1016/j.bbadis.2004.02.005 · DOI
  7. 10.1016/j.molimm.2008.08.276 · DOI · Paper page
  8. 10.2147/IJN.S30943 · DOI · Paper page
  9. 10.1016/j.ijpharm.2012.07.049 · DOI
  10. 10.1016/j.ejps.2011.11.014 · DOI
  11. 10.1016/j.exphem.2016.11.001 · DOI
  12. 10.1016/j.biomaterials.2007.10.015 · DOI
  13. 10.1016/j.addr.2011.06.017 · DOI · Paper page
  14. 10.1016/j.jconrel.2014.08.009 · DOI
  15. 10.1038/nnano.2017.47 · DOI · Paper page
  16. 10.1007/s10856-013-5034-y · DOI · Paper page
  17. 10.1002/mabi.201600074 · DOI
  18. 10.1016/j.biomaterials.2010.02.057 · DOI · Paper page
  19. 10.1002/marc.201200422 · DOI · Paper page
  20. 10.1039/C5NR03178H · DOI · Paper page
  21. 10.1002/marc.201200453 · DOI · Paper page
  22. 10.1021/bc200049d · DOI · Paper page
  23. 10.1021/la702917z · DOI · Paper page
  24. 10.1021/js9504043 · DOI · Paper page
  25. 10.1002/mabi.201500021 · DOI · Paper page
  26. 10.1021/acs.langmuir.5b00537 · DOI
  27. 10.1021/bc00030a001 · DOI · Paper page
  28. 10.1186/s12989-014-0064-2 · DOI · Paper page
  29. 10.1039/b921735e · DOI
  30. 10.1016/j.jconrel.2015.11.021 · DOI · Paper page
  31. 10.1034/j.1600-065X.2001.1800103.x · DOI · Paper page
  32. 10.3389/fimmu.2015.00262 · DOI · Paper page
  33. 10.1007/s00005-013-0229-y · DOI
  34. 10.1078/0171-2985-00144 · doi:10.1078/0171-2985-00144
  35. 10.1016/S0161-5890(01)00004-9 · DOI
  36. 10.1074/jbc.M112.341339 · DOI · Paper page
  37. 10.4049/jimmunol.180.4.2329 · DOI · Paper page
  38. 10.1016/S0005-2736(99)00013-9 · DOI
  39. Kovacsovics T., 1985, J. Immunol., 135, 2695, 10.4049/jimmunol.135.4.2695 · DOI
  40. 10.1093/intimm/2.5.413 · DOI · Paper page
  41. Bhakdi S., 1988, Clin. Exp. Immunol., 74, 459
  42. Tschopp J., 1993, J. Immunol., 151, 2159, 10.4049/jimmunol.151.4.2159 · DOI · Paper page
  43. Hattori R., 1989, J. Biol. Chem., 264, 9053, 10.1016/S0021-9258(18)81901-9 · DOI · Paper page
  44. Jenne D. E., 1991, J. Biol. Chem., 266, 11030, 10.1016/S0021-9258(18)99123-4 · DOI · Paper page
  45. 10.1073/pnas.85.18.6949 · DOI · Paper page
  46. 10.1023/A:1016286310475 · DOI
  47. 10.1016/j.drudis.2017.11.006 · DOI
  48. 10.2217/nnm.14.22 · DOI
  49. 10.2217/nnm.11.30 · doi:10.2217/nnm.11.30
  50. 10.1385/0-89603-441-0:301 · doi:10.1385/0-89603-441-0:301
  51. 10.1039/C5NR05290D · DOI
  52. 10.4049/jimmunol.1200816 · DOI
  53. 10.1016/j.jim.2009.11.003 · doi:10.1016/j.jim.2009.11.003
  54. 10.1104/pp.15.00361 · DOI
  55. 10.1021/pr101065j · DOI · Paper page
  56. 10.1074/mcp.O111.014522 · DOI
  57. 10.1002/pmic.200400999 · DOI
  58. 10.1016/j.nano.2013.01.011 · DOI

Cited by

See all 141

Metadata

Authors
Tavano, R., Gabrielli, L., Lubian, E., Fedeli, C., Visentin, S., Polverino De Laureto, P., Arrigoni, G., Geffner-Smith, A., Chen, F., Simberg, D., Morgese, G., Benetti, E. M., Wu, L., Moghimi, S. M., Mancin, F., & Papini, E.
Venue
ACS Nano
Published
2018-05-11
Volume
12
Issue
6
Pages
5834-5847
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W2800006797
Cited by
141
References
8
FWCI
3.70
Type
journal article
Language
en
Open access
green
Funders
  • Government of Guangdong Province (2015A050502002)
  • Universit? degli Studi di Padova
  • Guangzhou City (2016201604030050)
  • Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
  • RiboBio Co, Ltd.

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. https://app.cochat.ai/papers/10.1021/acsnano.8b01806
The paper
Tavano, R., Gabrielli, L., Lubian, E., Fedeli, C., Visentin, S., Polverino De Laureto, P., Arrigoni, G., Geffner-Smith, A., Chen, F., Simberg, D., Morgese, G., Benetti, E. M., Wu, L., Moghimi, S. M., Mancin, F., & Papini, E. (2018). C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. ACS Nano. https://doi.org/10.1021/acsnano.8b01806

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.